Dr. Bhanu Bahl is a Director for Harvard Catalyst’s Biomedical Informatics Program. At Harvard Catalyst, she is Director of the eagle-i, SHRINE, and PWTF evaluation projects. Bhanu is a physician with a broad informatics background in clinical research.
eagle-i is an open-source, open-ontology, semantic-search application, implemented across a network of 40 institutions, dedicated to the discovery of biomedical resources to facilitate & speed up translational science research.
The Shared Health Research Information Network (SHRINE) is a web-based query tool that allows investigators to determine the aggregate number of patients accros multi-site hospitals for clinical criteria of interest (currently demographics, diagnoses, medications, and selected laboratory values).
Prevention and Wellness Trust Fund (PWTF) evaluation is a project to estimate the impact of PWTF interventions on clinical and cost outcomes.The PWTF provides more than $42 million to 9 community-clinical partnerships throughout the state of Massachusetts to reduce healthcare costs, decrease preventable risk factors, reduce the prevalence of preventable health conditions, and improve management of existing chronic disease.
Bhanu is also director of software Quality Assurance Shared Services (QASS) at Harvard Catalyst. The QASS supports software quality and validation needs for 37+ Harvard Catalyst informatics projects leveraging technology and process optimization in order to ensure quality, robustness, and timeliness of deliverables.
In her free time, Bhanu volunteers for meditation programs in the community and is a committee co-chair for Harvard Joint Committee on the Status of Women (JCSW).